Ekso Bionics
$5.759876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$5.75
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.01 (-0.17%) Today
+$0.03 (+0.52%) As of 5:00 PM EST after-hours
Why Robinhood?
You can buy or sell Ekso Bionics and other stocks, options, and ETFs commission-free!
About EKSO
Ekso Bionics Holdings, Inc. engages in the design, development, and sale of exoskeleton technology that currently has applications in healthcare and industrial markets. It operates through the following business segments: EksoHealth, EksoWorks, and Other. The EksoHealth segment consists of the engineering, manufacture, and sale of exoskeletons for applications in the medical markets. The EksoWorks segment offers exoskeleton devices to allow able-bodied users to perform heavy duty work for extended periods. The company was founded on January 30, 2012 and is headquartered in Richmond, CA. The listed name for EKSO is Ekso Bionics Holdings, Inc. Common Stock.
CEO
Jack Peurach
Employees
68
Headquarters
Richmond, California
Founded
2012
Market Cap
47.57M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
106.75K
High Today
$5.86
Low Today
$5.66
Open Price
$5.74
Volume
43.46K
52 Week High
$10.74
52 Week Low
$2.25
Collections
EKSO Earnings
-$1.84
-$1.23
-$0.61
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Feb 25, After Hours